Filter your search

Search Report Keyword
Price
CATEGORIES
  • Biotechnology
  • Diagnostics
  • Healthcare
  • Medical Devices
  • Pharmaceuticals

Knowledge Center Sidebar

Most Popular Research

DiagnosticsX

Kalorama Information is the authoritative market research source for the diagnostics industry. Find essential insights, market shares, sales segmentation and projections for in vitro diagnostics (IVD) and medical imaging markets. Kalorama’s reports, including The Worldwide Market for In Vitro Diagnostic (IVD) Tests, 13th edition, analyze the global in vitro diagnostics market, now worth approximately $83.3 billion. Our diagnostics market research covers trends in health care service delivery, including the rapidly advancing diagnostic laboratory technology industry. Discover emerging diagnostics market niches in our updated reports that present the trends, technologies, customer needs, and major suppliers currently shaping the diagnostics industry.
Molecular Assays
Point-of-Care
Immunoassays
Infectious Disease
Clinical Chemistry
Oncology/Hematology
Lab Testing Services
Medical Imaging

  • Molecular Diagnostics for Pharmacogenetic Testing: Testing volume, cost per test, and market potential
    $995 – $1,990
    The field of pharmacogenetics promises to open up new opportunities for the diagnostic industry at the same time it opens the door to more effective therapeutics. Pharmacogenetics is based on the principle that the effects of a given medication when administered to a patient are determined, at least in part, by his or her genetic […]
    October 1, 2004
  • U.S. Market for Molecular Diagnostics, 2nd Edition
    $3,500 – $7,000
    Molecular diagnostics are seen as being a major breakthrough in medical science. While the technology itself has broad applications to such areas as agricultural bioterrorism and environmental science, medical and medical research applications have provided the primary focus. As a result, great things have been predicted for the development and use of new therapeutics based […]
    May 1, 2004
  • Diagnostics for Emerging Infectious Disease Threats Volume III: Bacterial Disease
    $1,995 – $3,990
    The recent terrorism events, in addition to the ease of travel that allows infectious diseases to spread, and technology developments drive the renewed interest in clinical and environmental infectious disease diagnostics. The combined public health and bio-terrorism markets of several bacterial and protozoan diseases are estimated to be nearly $100 million. This report, the final […]
    April 1, 2004
  • The U.S. Market for Interventional Radiology Products
    $3,500 – $7,000
    Changing demographics are spurring dynamic growth in the interventional radiology market. The angioplasty balloon, coronary stent, vascular closure, and other associated equipment markets will experience healthy growth over the next 5 years. Persons over the age of 65 will be a major segment of the population in coming years. Chronic diseases and unhealthy habits such […]
    April 1, 2004
  • Diagnostics for Emerging Infectious Disease Threats, Volumes I - III
    $3,995 – $7,990
    A host of new and old infectious diseases have emerged on the world stage, presenting familiar and novel challenges to public health officials. New strains of once controlled bacteria, new immunocomprimised patient populations, and new bioterror threats have spurred diagnostics companies to develop new tests and kits to meet the demand. Kalorama has assembled the […]
    March 1, 2004
  • Diagnostics for Emerging Infectious Disease Threats Volume II: Viral Disease
    $1,496 – $2,992
    Severe Acute Respiratory Syndrome (SARS), which was a new and unidentified disease when it first affected people, ripped through Asia and Toronto from late 2002 into the summer of 2003, before being contained for the season. Taiwan with just 346 reported cases performed 10,000 diagnostic tests. Three years after West Nile Virus (WNV) first appeared […]
    December 1, 2003
  • Diagnostics for Emerging Infectious Disease Threats Volume I: Prion Disease
    $1,496 – $2,992
    Diagnostic testing for prion diseases has become more important as countries increase the number of tests to battle the potential public health problem. Academic, government, and industry organizations continue to develop diagnostic testing technologies and policies as preventative measures. The number of prion diagnostic technologies being used and developed for prion diseases primarily reflects the […]
    October 1, 2003
  • Genetic Testing: Markets and Users in Medical, Forensic, Paternity, and Food Safety Applications
    $2,625 – $5,250
    Genetic testing is already in widespread use and will continue to grow in many application areas in the next five years. The number of companies offering genetic testing services and/or commercial genetic testing products continues to grow around the world. There are at least 50 companies offering genetic testing services or commercial products for a […]
    May 1, 2003
  • In Vitro Diagnostic Tests and Systems: The World Outside the United States
    $596 – $1,192
    To succeed in the diagnostics market of the 21st Century, a company has to have either a strong niche position in a particular market segment or be a jack of all trades. In either case, a full or comprehensive menu is critical. Why reinvent the wheel? Most tests and systems are already available somewhere, offered […]
    February 1, 2003